Duration of protection from clinical hepatitis A disease after vaccination with VAQTA.

@article{Wiens1996DurationOP,
  title={Duration of protection from clinical hepatitis A disease after vaccination with VAQTA.},
  author={Brian L. Wiens and Norman R. Bohidar and Joseph G. Pigeon and Judith Egan and William Hurni and Lois Brown and Barbara J. Kuter and DavidR. Nalin},
  journal={Journal of medical virology},
  year={1996},
  volume={49 3},
  pages={
          235-41
        }
}
Recent papers examining the expected persistence of anti-hepatitis A virus antibody following vaccination with inactivated hepatitis A vaccine have estimated that geometric mean antibody levels will remain above cut-off levels for 10-30 years. However, the methodology used in these papers did not take into account any estimates of variability between subjects. In this paper data from the persistence of antibody after the administration of another vaccine, VAQTA (hepatitis A vaccine, inactivated… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.

  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
  • 2015
VIEW 2 EXCERPTS
CITES BACKGROUND